Shailendra Kumar Verma

PeerJ Editor & Reviewer

Summary

Dr. Shailendra Kumar Verma is currently a postdoctoral fellow at La Jolla Institute for Immunology, California, USA. He pursued his Ph.D. from Central Drug Research Institute, India in the field of vaccine immunology. Dr. Verma joined DRDE, and had been a scientist since 2005 to 2021. His major research area focused onto the vaccine and therapeutic development against infectious diseases. He has published more than 25 publications in peer reviewed journals of highly repute. Dr. Verma has more than 15 years of research experience in infection and immunology. His present research at La Jolla institute for Immunology is focused onto the vaccine/therapeutic development against SARS-CoV-2 and ZIKA virus.

COVID-19 Immunology Infectious Diseases Virology

Editorial Board Member

PeerJ - the Journal of Life & Environmental Sciences

Past or current institution affiliations

UC San Diego

Work details

Postdoctoral Fellow

La Jolla Institute for Immunology

Center for Infectious Disease and Vaccine Research

Postdoctoral fellow

Identities

@Shail202280

Websites

Google Scholar

Academic Editor on

February 22, 2024

Exploratory study to characterise the individual types of health literacy and beliefs and their associations with infection prevention behaviours amid the COVID-19 pandemic in Japan: a longitudinal study

Mao Yagihashi, Michio Murakami, Mai Kato, Asayo Yamamura, Asako Miura, Kei Hirai

https://doi.org/10.7717/peerj.16905 PubMed 38406277

September 18, 2023

Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study

Katharina Hoeter, Elmo Neuberger, Susanne Fischer, Manuel Herbst, Ema Juškevičiūtė, Kira Enders, Heidi Rossmann, Martin F. Sprinzl, Perikles Simon, Marc Bodenstein, Michael Schaefer

https://doi.org/10.7717/peerj.16072 PubMed 37744227

May 15, 2023

The effectiveness of hepatitis B vaccine in toddlers based on the five-year period national basic health research (Riskesdas 2007, 2013 and 2018) in Indonesia

Christina Safira Whinie Lestari, Rita Marleta Dewi, Sunarno Sunarno, Armedy Ronny Hasugian, Sarwo Handayani, Masri Sembiring Maha, Novaria Sari Dewi Panjaitan, Nathalia Ningrum, Meiriani Sari, Firda Fairuza

https://doi.org/10.7717/peerj.15199 PubMed 37214093

Signed reviews submitted for articles published in PeerJ Note that some articles may not have the review itself made public unless authors have made them open as well.

February 21, 2023

Symptoms, the GerdQ score and patients’ characteristics do not predict gastroesophageal reflux disease in patients with proton-pump-inhibitor-refractory reflux symptoms—results from a large prospective database

Joachim Labenz, Merlissa Menzel, Oliver Hirsch, Matthias Müller, Christian Labenz, Charles Christian Adarkwah

https://doi.org/10.7717/peerj.14802 PubMed 36846452